絲聚蛋白(FLG)重組蛋白
Recombinant Filaggrin (FLG)
Profilaggrin
- 編號URPJ103Hu01
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源原核表達(dá)
- 宿主E.coli
- 內(nèi)毒素水平<1.0EU/µg(LAL法測定)
- 亞細(xì)胞定位細(xì)胞質(zhì)
- 預(yù)測分子量17.7kDa
- 實際分子量19kDa(差異分析請參閱說明書)
- 片段與標(biāo)簽Ser3905~Tyr4031 with N-terminal His Tag
- 緩沖液成份PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
- 性狀凍干粉
- 純度> 90%
- 等電點7.9
-
應(yīng)用
Positive Control; Immunogen; SDS-PAGE; WB.
如果需要有生物活性的蛋白，請參見活性蛋白。 - 下載 英文說明書 中文說明書
- 規(guī)格 10μg50μg 200μg 1mg 5mg
- 價格 ¥ 960 ¥ 2400 ¥ 4800 ¥ 14400 ¥ 36000
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
Gene sequencing
-
Figure. SDS-PAGE
-
通過ISO 9001、ISO 13485質(zhì)量體系認(rèn)證
序列
用法
Reconstitute in 10mM PBS (pH7.4) to a concentration of 0.1-1.0 mg/mL. Do not vortex.
儲存
避免反復(fù)凍融。2-8°C不超過一個月，-80°C不超過12個月。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| URPJ103Hu02 | 絲聚蛋白(FLG)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPJ103Hu01 | 絲聚蛋白(FLG)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPJ103Hu05 | 絲聚蛋白(FLG)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UEPJ103Hu61 | 絲聚蛋白(FLG)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPJ103Hu03 | 絲聚蛋白(FLG)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| URPJ103Hu04 | 絲聚蛋白(FLG)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UPAJ103Hu01 | 絲聚蛋白(FLG)多克隆抗體 | WB |
| UPAJ103Hu02 | 絲聚蛋白(FLG)多克隆抗體 | WB; IHC; ICC; IP. |
| ULAJ103Hu71 | 絲聚蛋白(FLG)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| ULAJ103Hu83 | 絲聚蛋白(FLG)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| ULAJ103Hu81 | 絲聚蛋白(FLG)多克隆抗體(異硫氰酸熒光素標(biāo)記) | WB; IHC; ICC; IF. |
| UMAJ103Hu21 | 絲聚蛋白(FLG)單克隆抗體 | WB; IHC; ICC; IP. |
| USEJ103Hu | 絲聚蛋白(FLG)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| USCJ103Hu | 絲聚蛋白(FLG)檢測試劑盒(化學(xué)發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
| ULMJ103Hu | 絲聚蛋白(FLG)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻(xiàn)
| 雜志 | 參考文獻(xiàn) |
| Journal of the Egyptian Women's Dermatologic Society | Filaggrin R501x and 2282del4 gene mutations and its tissue levels in patients with chronic plaque psoriasis [LWW: 01000] |
| ?Inflammation & Allergy-Drug Targets | Neuromodulatory and Anti-Inflammatory Ingredient for Sensitive Skin: In Vitro Assessment [Pubmed:24931812] |
| PLoS?One | Protective Effects of Triphala on Dermal Fibroblasts and Human Keratinocytes [Pubmed:26731545] |
| Journal of food biochemistry | In vitro anti-inflammatory and skin protective properties of extract comprising ceramides from de-oiled rice bran [doi:10.1111] |
| European Journal of Pharmacology | Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin. [pubmed:28736282] |
| Journal of Dermatological?Science | A novel, topical, nonsteroidal, TRPV1 antagonist, PAC-14028 cream improves skin barrier function and exerts anti-inflammatory action through modulating epidermal?… [Pubmed:29752146] |
| Journal of Traditional and Complementary Medicine | In vitro anti-inflammatory and skin protective properties of Virgin coconut oil [10.1016:j.jtcme.2017.06.012] |
| Clinical and Molecular Allergy | Markers of atopic dermatitis, allergic rhinitis and bronchial asthma in pediatric patients: correlation with filaggrin, eosinophil major basic protein and?… [] |
| Intractable?&?Rare?Diseases?Research | Filaggrin, major basic protein and leukotriene B4: Biomarkers for adult patients of bronchial asthma, atopic dermatitis and allergic rhinitis [Pubmed: 30560019] |
| Dermatology and Therapy | Epidermal and Dermal Hallmarks of Photoaging are Prevented by Treatment with Night Serum Containing Melatonin, Bakuchiol, and Ascorbyl?… [] |
| 日本化粧品技術(shù)者會誌 | 糖化に起因する表皮機能低下に対するワイルドタイムエキスの防御効果 [] |
| J Dermatol | Filaggrin‐gene mutation has minimal effect on the disease severity in the lesions of atopic dermatitis [34322929] |
留言咨詢
